A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation? (Q41749692)
Jump to navigation
Jump to search
scientific article published on 20 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation? |
scientific article published on 20 April 2015 |
Statements
1 reference
A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation? (English)
1 reference
Yue Yang
1 reference
Chao Lv
1 reference
Chao An
1 reference
Qin Feng
1 reference
Yuanyuan Ma
1 reference
Shaolei Li
1 reference
Jia Wang
1 reference
Jianzhi Zhang
1 reference
Xing Wang
1 reference
Shi Yan
1 reference
Jian Fang
1 reference
Yinxiang Wang
1 reference
Fenlai Tan
1 reference
20 April 2015
1 reference
1 reference
16
1 reference
6
1 reference
e173-81
1 reference
Identifiers
1 reference
1 reference